Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ADAM family proteins are type I transmembrane, zinc-dependent metalloproteases. This family has multiple conserved domains, including a signal peptide, a pro-domain, a metalloprotease domain, a disintegrin (DI) domain, a cysteine-rich (Cys) domain, an EGF-like domain, a transmembrane domain, and a cytoplasmic domain. The Cys and DI domains may play active roles in regulating proteolytic activity or substrate specificity. ADAM19 has an autolytic processing activity within its Cys domain, and the processing is necessary for its proteolytic activity. To identify a new physiological function of ADAM19, we screened for associating proteins by using the extracellular domain of ADAM19 in a yeast two-hybrid system.
Cysteine-rich protein 2
(
CRIP2
) showed an association with ADAM19 through its DI and Cys domains. Sequence analysis revealed that
CRIP2
is a secretable protein without a classical signal.
CRIP2
secretion was increased by overexpression of ADAM19 and decreased by suppression of ADAM19 expression. Moreover,
CRIP2
secretion increased in parallel with the autolytic processing of ADAM19 stimulated by
lipopolysaccharide
. These findings suggest that ADAM19 autolysis is activated by
lipopolysaccharide
and that ADAM19 promotes the secretion of
CRIP2
.
...
PMID:ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2. 2046 Jan 9